Fort Pitt Capital Group, LLC Bristol Myers Squibb CO Transaction History

Fort Pitt Capital Group, LLC

$3.27 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $15.1 Million - $18 Million	-311,020 Reduced 32.09%	658,324 $33.8 Million
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $5.14 Million - $5.75 Million	88,790 Added 10.08%	969,344 $56.3 Million
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $1.52 Million - $1.69 Million	23,919 Added 2.79%	880,554 $56.3 Million
Q1 2023 May 16, 2023	BUY	$65.71 - $74.53 $2.94 Million - $3.34 Million	44,770 Added 5.51%	856,635 $59.4 Million
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $843,810 - $999,190	12,322 Added 1.54%	811,865 $58.4 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $3,642 - $2.15 Million	28,016 Added 3.63%	799,543 $56.8 Million
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $936,798 - $1.03 Million	12,900 Added 1.7%	771,527 $59.4 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $7.74 Million - $9.28 Million	125,900 Added 19.9%	758,627 $55.4 Million
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $3.9 Million - $4.54 Million	72,639 Added 12.97%	632,727 $39.5 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $4.29 Million - $5.02 Million	72,494 Added 14.87%	560,088 $33.1 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $2.6 Million - $2.83 Million	42,045 Added 9.44%	487,594 $32.6 Million
Q1 2021 Apr 16, 2021	BUY	$59.34 - $66.74 $1.65 Million - $1.85 Million	27,789 Added 6.65%	445,549 $28.1 Million
Q4 2020 Feb 24, 2021	BUY	$57.74 - $65.43 $24.1 Million - $27.3 Million	417,343 Added 100082.25%	417,760 $25.9 Million
Q4 2020 Feb 23, 2021	SELL	$57.74 - $65.43 $18.3 Million - $20.7 Million	-316,230 Reduced 99.87%	417 $25.9 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $1.15 Million - $1.28 Million	20,102 Added 6.78%	316,647 $19.1 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $1.21 Million - $1.41 Million	-22,053 Reduced 6.92%	296,545 $17.4 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $2.06 Million - $3 Million	44,476 Added 16.22%	318,598 $17.8 Million
Q4 2019 Feb 18, 2020	BUY	$49.21 - $64.19 $8.38 Million - $10.9 Million	170,362 Added 164.19%	274,122 $17.6 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $4.44 Million - $5.26 Million	103,760 New	103,760 $5.26 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $262,722 - $290,513	-5,888 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $136,081 - $162,260	-3,016 Reduced 33.87%	5,888 $281,000
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $71,482 - $92,695	1,466 Added 19.71%	8,904 $463,000
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $13,963 - $15,749	253 Added 3.52%	7,438 $462,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $84,031 - $104,735	1,663 Added 30.12%	7,185 $398,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $330,878 - $380,907	5,522 New	5,522 $349,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Pitt Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Pitt Capital Group, LLC with notifications on news.

Account